Alvotech H1 FY26 adjusted EBITDA drops 12.7% to USD 46.9 million; revenue falls 30.8% to USD 211.9 million - ALVO News | RalliesAlvotech H1 FY26 adjusted EBITDA drops 12.7% to USD 46.9 million; revenue falls 30.8% to USD 211.9 million
A
ALVO• H1 FY26 results
- Alvotech posted adjusted revenue of USD 211.9 million, down 30.8% from a year earlier.
- Adjusted EBITDA fell 12.7% to USD 46.9 million; gross margin held at 54%, down 1 percentage point.
- Product and service revenue slid 48.3% to USD 105.9 million; license and other revenue rose 4.4% to USD 105.7 million.
Cash position, financing and outlook
- Cash balance ended at USD 142.8 million, down from Dec. 31, 2025; the company raised about USD 165 million in equity financing.
- Alvotech resubmitted U.S. BLAs for AVT05 and AVT06; FDA decisions are anticipated in Q4 2026.
- The company sees full-year revenue at USD 650 million to USD 700 million.
